Antibody Drug Conjugate Market – Global Partnerships Accelerate ADC Research
Strategic partnerships are becoming central to the antibody drug conjugate market. Large pharmaceutical companies, biotechnology firms, academic centers, and platform-technology specialists are collaborating to develop new ADC candidates, optimize payloads, and expand clinical research. North America leads the market, accounting for about 45% of global revenue in 2024, supported by substantial...
0 Comments 0 Shares 104 Views 0 Reviews